We further evaluated the effects of OFD1 depletion on tumorigenesis and progression in vivo, using mouse xenograft models with highly malignant pancreatic cancer, colon cancer, and triple-negative breast cancer cells. The gene discussed is OFD1; the disease is pancreatic neoplasm.